Search
Avalo Therapeutics Inc
AVTXAdd to Watchlist
16.450USD
+0.330+2.05%
Market hours 09/14, 11:43（ET）
870.22MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+2.05%
5 Days
-14.46%
1 Month
-15.42%
6 Months
+4.11%
Year to Date
-9.42%
1 Year
+54.39%
Key Figures
16.308Open
16.510High
19.83KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.04%Turnover Ratio
16.120Prev. Close
16.145Low
323.46KTurnover
LossP/E Static
1.94P/B
0.00%Div Yield TTM
-71.09%ROA
24.27052wk High
0.05Volume Ratio
-35.13MNet Profit
52.90MShares
-5.5639EPS TTM
0.84Beta
-88.76%ROE
9.54052wk Low
2.26%Amplitude
100.00%Gross Margin
870.22MMarket Cap
1.58Reward/Risk
5.45%Risk Rate
Avalo Therapeutics Inc's Score
-0.13vs previous score
Forecast9.14
Financial Health5.15
Technical4.12
Valuation Dimensions7.46
Institutional Confidence5.00
Risk Assessment5.51
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Avalo Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.83/-0.58
Revenue / Forecast
--/0.00
Avalo Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolAVTX
Number of employees23
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Fidelity Management & Research Company LLC | 5.13% |
| T. Rowe Price Investment Management, Inc. | 3.51% |
| BVF Partners L.P. | 3.27% |
| Nantahala Capital Management, LLC | 2.98% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 25.28% |
| Investment Advisor | 17.19% |
| Investment Advisor/Hedge Fund | 7.29% |
| Private Equity | 3.96% |
Related Instruments
+2.79%
+1.19%
+2.47%
+2.25%
+0.69%
+1.86%
+0.59%
+1.36%
+0.38%
+0.71%
+0.74%
+0.99%
+1.47%
+1.41%
+3.95%
+1.11%
+1.71%
+2.08%
+0.44%
-0.55%Popular Instruments
52502.600
-50.400 (-0.10%)
29188.000
-180.900 (-0.62%)
7632.200
-24.400 (-0.32%)
14394.000
-62.000 (-0.43%)
63443.000
-1236.000 (-1.91%)
6281.900
-37.900 (-0.60%)
100.653
+2.296 (+2.33%)
334.220
+1.950 (+0.59%)
211.990
-6.300 (-2.89%)
4296.810
-51.240 (-1.18%)
FAQs
What is the current price of Avalo Therapeutics Inc (AVTX)?
The current price of Avalo Therapeutics Inc (AVTX) is 16.12.
What is the symbol of Avalo Therapeutics Inc?
The ticker symbol of Avalo Therapeutics Inc is AVTX.
What is the 52-week high of Avalo Therapeutics Inc?
The 52-week high of Avalo Therapeutics Inc is 24.27.
What is the 52-week low of Avalo Therapeutics Inc?
The 52-week low of Avalo Therapeutics Inc is 9.54.
What is the market capitalization of Avalo Therapeutics Inc?
The market capitalization of Avalo Therapeutics Inc is 298.43M.
Is Avalo Therapeutics Inc (AVTX) currently rated as Buy, Hold, or Sell?
According to analysts, Avalo Therapeutics Inc (AVTX) has an overall rating of STRONG BUY, with a price target of 44.91.
What is the Earnings Per Share (EPS TTM) of Avalo Therapeutics Inc (AVTX)?
The Earnings Per Share (EPS TTM) of Avalo Therapeutics Inc (AVTX) is -5.56.